BioNTech, a next-generation immunotherapy company, and Autolus Therapeutics, a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, have announced a strategic collaboration aimed at advancing both companies’ autologous CAR-T…
UK: BioNTech purchases US$200m of Autolus ADS as part of strategic collaboration
…
…






